For people with chronic sleep problems, treatment often means medication, behavioral therapy or changes in daily habits.
Researchers in Texas are exploring a very different possibility: a wearable patch that gently stimulates the brain while a person sleeps.
The experimental device is called NEUSLeeP. Developed by a team led by the University of Texas at Austin, it was tested in 28 people in research published in Nature Communications.
NEUSLeeP focuses on REM sleep, one of the most fascinating parts of the nightly sleep cycle. REM stands for rapid eye movement because the eyes move quickly beneath closed eyelids during this stage.
Dreaming often becomes vivid during REM sleep, but dreaming is only part of the story. Researchers believe this stage helps the brain process memories and emotions and may play a role in how people adapt to stressful experiences.
A typical night’s sleep includes repeated cycles of REM and non-REM sleep. The amount and timing of each stage change throughout the night, with longer periods of REM often occurring toward morning.
When sleep is disrupted, these patterns can change. Researchers have found links between abnormal REM sleep and several conditions, including insomnia, depression and post-traumatic stress disorder.
That has created interest in ways to influence REM sleep directly. Drugs can affect sleep stages, but they may also cause unwanted effects and do not always address the specific brain circuits involved.
The UT Austin researchers developed a patch that combines two technologies. Electrodes record electrical signals from the brain, while another part of the device sends low-intensity ultrasound through the skin.
Ultrasound is best known for creating images during pregnancy and medical examinations. But sound waves can also interact with nerve tissue, and scientists are studying whether carefully targeted ultrasound can safely change activity in selected parts of the brain.
Reaching deep brain areas without surgery is a major challenge. Some forms of brain stimulation work mainly near the surface, while implanted devices can reach deeper areas but require an operation.
The researchers say their wearable system offers a possible middle path. It is designed to reach deeper sleep-related circuits without placing electrodes or other hardware inside the brain.
Just as importantly, the device can monitor brain activity while stimulation is taking place. This creates the possibility of a closed-loop system in which treatment responds to what the brain is actually doing rather than delivering the same stimulation continuously.
In the small human study, the results were encouraging. Participants receiving the stimulation reached REM sleep an average of 43 minutes earlier.
They also remained in REM for about 16 minutes longer. Effects were reported in healthy sleepers as well as participants who had some difficulty with sleep.
Participants generally described the wearable as comfortable, and the researchers reported minimal adverse effects. These early safety findings matter because any future home sleep device would need to be easy to tolerate for long periods.
The study also produced clues that the effects might extend beyond sleep itself. In healthy participants, stimulation increased heart rate variability, a measure of how the timing between heartbeats changes.
Higher heart rate variability is sometimes associated with better flexibility in the body’s automatic stress-response systems. However, it is not a simple score of health, and changes in this measure alone do not prove that a person has become less stressed or psychologically healthier.
Brain imaging showed changes in circuits involved in emotion. This finding fits with theories that REM sleep helps the brain process emotional experiences, but it does not yet prove that increasing REM will improve mood.
That distinction is particularly important because the researchers see possible future applications in depression and PTSD. People with these conditions can experience major sleep disturbances, and better sleep could potentially become one part of treatment.
The team also hopes to study chronic insomnia. Insomnia affects far more than the number of hours a person sleeps and can involve difficulty falling asleep, repeated waking, early waking and poor-quality sleep.
Future trials will need to determine whether changing REM sleep actually makes people feel and function better during the day. Clinical success would mean more than producing a different pattern on a sleep recording.
Researchers would want to know whether patients experience better sleep quality, improved concentration, less daytime tiredness or meaningful changes in symptoms. Long-term safety would also need careful examination.
The current study has obvious limitations. Twenty-eight participants is a small sample, and results from an early experiment can look different when a technology is tested in hundreds of people with diverse ages, health conditions and sleep disorders.
Sleep itself is also highly variable. Stress, caffeine, alcohol, medicines, illness, light exposure and a person’s daily schedule can all affect how quickly REM begins and how long it lasts.
Another unanswered question is whether more REM is always desirable. The brain normally balances several sleep stages, including deep non-REM sleep, which has its own important roles in physical recovery and memory.
The most interesting part of NEUSLeeP may therefore be its ability to target and monitor sleep rather than simply its ability to increase REM. A future device that recognizes a person’s sleep state and responds at the right moment could be more precise than a treatment that affects the brain throughout the night.
The technology could also give scientists a new tool for studying sleep outside traditional laboratories. Conventional sleep studies often require many sensors and an unfamiliar overnight environment, which can make sleep feel less natural.
A comfortable wearable system could eventually allow researchers to collect information in people’s homes. That could provide a clearer picture of how sleep changes from night to night in everyday life.
The project is already moving toward possible commercialization. The researchers are working with Discovery to Impact, the University of Texas at Austin’s commercialization unit, and a patent application has been filed for the technology.
Commercial development, however, does not mean the device has already been proven as a medical treatment. It will still require larger clinical studies and appropriate regulatory review before doctors could routinely prescribe it.
Overall, the Nature Communications study is an exciting early demonstration rather than a final answer to sleep disorders. It shows that a soft, noninvasive wearable may be able to influence deep sleep-related brain circuits while simultaneously recording the brain’s response.
If the findings hold up in larger trials, NEUSLeeP could help researchers move toward personalized sleep treatment that works with the brain in real time. The bigger test now is whether changing REM sleep with the patch can produce lasting improvements in health, mood and daily life.
If you care about sleep health, please read studies about refined carbs linked to insomnia risk, and dietary choices for insomnia management.
